Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer

被引:130
|
作者
Jiang, Meng [1 ]
Li, Chang-Li [2 ]
Luo, Xiao-Mao [3 ,4 ]
Chuan, Zhi-Rui [3 ,4 ]
Lv, Wen-Zhi [5 ]
Li, Xu [6 ]
Cui, Xin-Wu [1 ]
Dietrich, Christoph F. [7 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
[2] Hubei Prov Hosp Integrated Chinese & Western Med, Dept Geratol, 11 Lingjiaohu Ave, Wuhan 430015, Peoples R China
[3] Kunming Med Univ, Dept Med Ultrasound, Yunnan Canc Hosp, Kunming 650118, Yunnan, Peoples R China
[4] Kunming Med Univ, Affiliated Hosp 3, Kunming 650118, Yunnan, Peoples R China
[5] Julei Technol, Dept Artificial Intelligence, Wuhan 430030, Peoples R China
[6] South Cent Univ Nationalities, Sch Biomed Engn, 182 Minyuan Rd, Wuhan 430074, Peoples R China
[7] Hirslanden Clin, Dept Internal Med, Schanzlihalde 11, CH-3013 Bern, Switzerland
基金
中国博士后科学基金;
关键词
PPathological complete response; DDeep learning; RRadiomic nomogram; Locally advanced breast cancer; PREDICTION; ESTROGEN; NOMOGRAM; MRI;
D O I
10.1016/j.ejca.2021.01.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of the study was to develop and validate a deep learning radiomic nomogram (DLRN) for preoperatively assessing breast cancer pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) based on the pre- and post-treatment ultrasound. Methods: Patients with locally advanced breast cancer (LABC) proved by biopsy who proceeded to undergo preoperative NAC were enrolled from hospital #1 (training cohort, 356 cases) and hospital #2 (independent external validation cohort, 236 cases). Deep learning and handcrafted radiomic features reflecting the phenotypes of the pre- treatment (radiomic signature [RS] 1) and post-treatment tumour (RS2) were extracted. The minimum redundancy maximum relevance algorithm and the least absolute shrinkage and selection operator regression were used for feature selection and RS construction. A DLRN was then developed based on the RSs and independent clinicopathological risk factors. The performance of the model was assessed with regard to calibration, discrimination and clinical usefulness. Results: The DLRN predicted the pCR status with accuracy, yielded an area under the receiver operator characteristic curve of 0.94 (95% confidence interval, 0.91-0.97) in the validation cohort, with good calibration. The DLRN outperformed the clinical model and single RS within both cohorts (P < 0.05, as per the DeLong test) and performed better than two experts' prediction of pCR (both P < 0.01 for comparison of total accuracy). Besides, prediction within the hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative, HER2+ and triple-negative subgroups also achieved good discrimination performance, with an AUC of 0.90, 0.95 and 0.93, respectively, in the external validation cohort. Decision curve analysis confirmed that the model was clinically useful. Conclusion: A deep learning-based radiomic nomogram had good predictive value for pCR in LABC, which could provide valuable information for individual treatment. (C) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 105
页数:11
相关论文
共 50 条
  • [21] Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue
    Guangying Zheng
    Jie Hou
    Zhenyu Shu
    Jiaxuan Peng
    Lu Han
    Zhongyu Yuan
    Xiaodong He
    Xiangyang Gong
    BMC Medical Imaging, 24
  • [22] Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method
    Qu, Yu-Hong
    Zhu, Hai-Tao
    Cao, Kun
    Li, Xiao-Ting
    Ye, Meng
    Sun, Ying-Shi
    THORACIC CANCER, 2020, 11 (03) : 651 - 658
  • [23] Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients
    Baumgartner, Annina
    Tausch, Christoph
    Hosch, Stefanie
    Papassotiropoulos, Barbel
    Varga, Zsuzsanna
    Rageth, Christoph
    Baege, Astrid
    BREAST, 2018, 39 : 19 - 23
  • [24] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Fernández-Sánchez, M
    Gamboa-Dominguez, A
    Uribe, N
    García-Ulloa, AC
    Flores-Estrada, D
    Candelaria, M
    Arrieta, O
    MEDICAL ONCOLOGY, 2006, 23 (02) : 171 - 183
  • [25] IMMUNOHISTOCHEMICAL PREDICTORS OF THE CLINICAL AND PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER
    Rodionova, M.
    Ryabchikov, D.
    Portnoy, S.
    Vorotnikov, I.
    Chkhikvadze, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 130 - 131
  • [26] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Mónica Fernández-Sánchez
    Armando Gamboa-Dominguez
    Norma Uribe
    Ana Cristina García-Ulloa
    Diana Flores-Estrada
    Myrna Candelaria
    Oscar Arrieta
    Medical Oncology, 2006, 23 : 171 - 183
  • [27] Can mammographic breast density predict complete pathological response in patients with locally advanced breast cancer following neoadjuvant chemotherapy?
    Agarwal, Veenoo
    Spalding, Lisa
    Blick, Tony
    Thompson, Erik W.
    Dobrovic, Alexander
    Redfern, Andrew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 65 - 65
  • [28] A pathological complete response after neoadjuvant triplet chemotherapy for locally advanced transverse colon cancer
    Tominaga, Tetsuro
    Nonaka, Takashi
    Tabata, Kazuhiro
    Sawai, Terumitsu
    Nagayasu, Takeshi
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2020, 72 : 127 - 132
  • [29] CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
    Wilson Eduardo Furlan Matos Alves
    Murilo Bonatelli
    Rozany Dufloth
    Lígia Maria Kerr
    Guilherme Freire Angotti Carrara
    Ricardo Filipe Alves da Costa
    Cristovam Scapulatempo-Neto
    Daniel Tiezzi
    René Aloísio da Costa Vieira
    Céline Pinheiro
    BMC Cancer, 19
  • [30] Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
    Heidy Cedeño
    Rafael Araúz
    Fernando Cebamanos
    Idalmis de Torraza
    Ana Porcell
    BMC Cancer, 7 (Suppl 1)